132 related articles for article (PubMed ID: 1347353)
1. Testing an anti-HIV trio.
Lancet; 1992 Mar; 339(8794):672. PubMed ID: 1347353
[No Abstract] [Full Text] [Related]
2. The Delta trial.
Zaretsky MD
Lancet; 1997 Feb; 349(9048):358-9. PubMed ID: 9024402
[No Abstract] [Full Text] [Related]
3. [Anti-HIV therapy (1987-1994): from nothing to confusion].
Lissen E
Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
[No Abstract] [Full Text] [Related]
4. Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1.
Commun Dis Rep CDR Wkly; 1995 Oct; 5(42):209. PubMed ID: 7496435
[No Abstract] [Full Text] [Related]
5. Combination superior to zidovudine in Delta trial.
Choo V
Lancet; 1995 Sep; 346(8979):895. PubMed ID: 7564678
[No Abstract] [Full Text] [Related]
6. Trial of three drugs for HIV-infected patients.
Am Fam Physician; 1992 Apr; 45(4):1923. PubMed ID: 1313636
[No Abstract] [Full Text] [Related]
7. Current perspectives on antiretroviral therapy.
Fletcher CV
Pharmacotherapy; 1993; 13(6):627-33. PubMed ID: 7508101
[TBL] [Abstract][Full Text] [Related]
8. Anti-HIV therapy lowers risk of AIDS, death in patients with intermediate-stage HIV disease.
AIDS Patient Care; 1995 Dec; 9(6):303. PubMed ID: 11361440
[No Abstract] [Full Text] [Related]
9. A bend in the road--implications of ACTG 175 and Delta trials.
Hirsch MS; Yeni P
Antivir Ther; 1996 Jan; 1(1):6-8. PubMed ID: 11322260
[No Abstract] [Full Text] [Related]
10. HIV therapy advances. Pediatric antiretroviral choices.
Spector SA
AIDS; 1994 Sep; 8 Suppl 3():S15-8. PubMed ID: 7840911
[TBL] [Abstract][Full Text] [Related]
11. The use of nucleoside analogues in the treatment of HIV-infected children.
Husson RN; Pizzo PA
AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1059-64. PubMed ID: 1323984
[No Abstract] [Full Text] [Related]
12. Studies of zidovudine in combination with didanosine and zalcitabine.
Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of HIV. APhA Editorial Board on Pharmaceutical Care for Patients with HIV Infection.
Am Pharm; 1994 Feb; NS34(2):60-9; quiz 69-70. PubMed ID: 8166046
[No Abstract] [Full Text] [Related]
14. Therapy for human immunodeficiency virus infection -- what have we learned?
Corey L; Holmes KK
N Engl J Med; 1996 Oct; 335(15):1142-4. PubMed ID: 8813046
[No Abstract] [Full Text] [Related]
15. [Treatment by antiviral drugs of HIV-infected patients].
Mayaud C
Rev Pneumol Clin; 1993; 49(2):71-4. PubMed ID: 8272744
[No Abstract] [Full Text] [Related]
16. Managing HIV. Part 4: Primary therapy. 4.1 Antiretroviral therapies for HIV.
Crowe S; Cooper DA; Chambers DE
Med J Aust; 1996 Mar; 164(5):290-5. PubMed ID: 8628165
[TBL] [Abstract][Full Text] [Related]
17. [Antiretroviral therapy. Current status and perspectives].
Lüthy R
Internist (Berl); 1994 Oct; 35(10):896-900. PubMed ID: 8002223
[No Abstract] [Full Text] [Related]
18. A trial comparing nucleoside monotherapy with sequential therapy with 3 drugs in HIV-infected patients.
Roca B; Olmos P; Mínguez C; Arnedo A; Usó J; Teruel C; Segarra M; Sáez-Royuela A; Simón E
Scand J Infect Dis; 1998; 30(4):426-8. PubMed ID: 9817530
[TBL] [Abstract][Full Text] [Related]
19. Intermittent therapy.
Volberding PA
J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):454-6. PubMed ID: 8158538
[No Abstract] [Full Text] [Related]
20. [Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection].
Aguirrebengoa K; Mallolas J; Uriz J; Torres Tortosa M
Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():3-9. PubMed ID: 9053024
[No Abstract] [Full Text] [Related]
[Next] [New Search]
